High expression of IGF2-derived intronic miR-483 predicts outcome in hepatoblastoma.
CONCLUSIONS: The expansion of the four-miR signature by miR-483 serves as a useful biomarker to predict outcome of HB patients.
PMID: 32390604 [PubMed - as supplied by publisher]
Source: Cancer Biomarkers - Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research
More News: Biology | Cancer | Cancer & Oncology | Childhood Cancer | Hepatoblastoma | Liver | Study | Urology & Nephrology